Lv42
528 积分 2025-04-19 加入
In vivo CAR T cells gain traction, with AbbVie’s US$2.1 billion acquisition of Capstan Therapeutics
25天前
已完结
B cells and variant BAFF in autoimmune disease
25天前
已完结
Single-cell analysis of anti-BCMA CAR T cell therapy in patients with central nervous system autoimmunity
27天前
已完结
In Vivo mRNA CAR T Cell Engineering via Targeted Ionizable Lipid Nanoparticles with Extrahepatic Tropism
1个月前
已完结
Customizable mRNA Lipid Nanoparticles for Transfection of Primary Human T Cells
1个月前
已完结
CD19-Targeted CAR T Cells in Refractory Systemic Lupus Erythematosus
1个月前
已完结
A Phase 3 Trial of Atacicept in Patients with IgA Nephropathy
1个月前
已完结
2024 Diagnostic Criteria for Multiple Sclerosis—A Unified Approach
1个月前
已完结
Co‐Delivery of Multiple RNAs via Lipid Nanoparticles Enables Precise Gene Editing of CAR‐T Cells
1个月前
已完结
In vivo CAR-T cell engineering in refractory SLE
1个月前
已完结
皖公网安备34019202002308
